Taurolithocholic acid-3 sulfate impairs insulin signaling in cultured rat hepatocytes and perfused rat liver

Cellular Physiology and Biochemistry

Volumn 21, Issue 1-3, 2008, Pages 137-150

  Mannack, Gudrun ^a   Graf, Dirk ^a   Donner, Markus M ^a   Richter, Lisa ^a   Görg, Boris ^a   Vom Dahl, Stephan ^a   Häussinger, Dieter ^a   Schliess, Freimut ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Bile acids; Cell volume; Insulin Resistance; PKB; Proteolysis; Rapamycin; Tauroursodeoxycholate

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BILE ACID; BUCLADESINE; EPIGALLOCATECHIN GALLATE; INSULIN; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM ION; PROTEIN KINASE B; PROTEIN KINASE C INHIBITOR; RAPAMYCIN; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BILE DUCT LIGATION; CELL VOLUME; CHOLESTASIS; CONTROLLED STUDY; ENZYME ASSAY; INSULIN RESISTANCE; LIVER CELL; LIVER CELL CULTURE; LIVER PERFUSION; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MAMMALIA; RATTUS;

EID: 38349181088     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113756     Document Type: Article

References (49)

1. Houten SM, Watanabe M, Auwerx J: Endocrine functions of bile acids. EMBO J 2006;25:1419-1425.
2. Lazaridis KN, Gores GJ, Lindor KD: Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 2001;35:134-146.
3. Beuers U: Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006;3:318-328.
4. Häussinger D, Kurz AK, Wettstein M, Graf D, vom Dahl S, Schliess F: Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 2003;124:1476-1487.
5. Han SI, Studer E, Gupta S, Fang Y, Qiao L, Li W, Grant S, Hylemon PB, Dent P: Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes. Hepatology 2004;39:456-463.
6. Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R., Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, Dent P: Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell 2001;12:2629-2645.
7. Reinehr R, Graf D, Häussinger D: Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 2003;125:839-853.
8. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999;103:137-145.
9. Claudel T, Staels B, Kuipers F: The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 2005;25:2020-2030.
10. Dent P, Han SI, Mitchell C, Studer E, Yacoub A, Grandis J, Grant S, Krystal GW, Hylemon PB: Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes. Biochem Pharmacol 2005;70:1685-1696.
11. Bouscarel B, Gettys TW, Fromm H, Dubner H: Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am J Physiol 1995;268:G300-310.
12. Ikegami T, Matsuzaki Y, Fukushima S, Shoda J, Olivier JL, Bouscarel B, Tanaka N: Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells. Hepatology 2005;41:896-905.
13. Graf D, Kohlmann C, Haselow K, Gehrmann T, Bode JG, Häussinger D: Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver. Hepatology 2006;44:1206-1217.
14. Podevin P, Rosmorduc O, Conti F, Calmus Y, Meier PJ, Poupon R: Bile acids modulate the interferon signalling pathway. Hepatology 1999;29:1840-1847.
15. Kurz AK, Block C, Graf D, vom Dahl S, Schliess F, Häussinger D: Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. Biochem J 2000;350:1207-1213.
16. Graf D, Kurz AK, Fischer R, Reinehr R, Häussinger D: Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 2002;122:1411-1427.
17. Schliess F, Reissmann R, Reinehr R, vom Dahl S, Häussinger D: Involvement of integrins and Src in insulin signaling towards autophagic proteolysis in rat liver. J Biol Chem 2004;279:21294-21301.
18. vom Dahl S, Häussinger D: Experimental methods in hepatology. Guidelines of the German Association for the Study of the Liver (GASL). Liver perfusion-technique and applications. Z Gastroenterol 1997;35:221-226.
19. Graf D, Kurz AK, Reinehr RM, Fischer R, Kircheis G, Häussinger D: Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 2003;36:602-614.
20. Warskulat U, Wettstein M, Häussinger D: Osmoregulated taurine transport in H4IIE rat hepatoma cells and perfused rat liver. Biochem J 1997;321:683-690.
21. Glasova H, Berghaus TM, Kullak-Ublick GA, Paumgartner G, Beuers U: Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. Eur J Clin Invest 2002;32:437-442.
22. Schoemaker MH, Conde-de-la-Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H: Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 2004;39:1563-1573.
23. Rippin SJ, Hagenbuch B, Meier PJ, Stieger B: Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 2001;33:776-782.
24. von Dippe P, Levy D: Expression of the bile acid transport protein during liver development and in hepatoma cells. J Biol Chem 1990 15;265:5942-5945.
25. Lizcano JM, Alessi DR: The insulin signalling pathway. Curr Biol 2002;12:R236-R238.
26. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 1995;92:7686-7689.
27. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001 20;98:13681-13686.
28. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995;364:229-233.
29. Graf D, Reinehr R, Kurz AK, Fischer R, Häussinger D: Inhibition of taurolithocholate 3-sulfate-induced apoptosis by cyclic AMP in rat hepatocytes involves protein kinase A-dependent and -independent mechanisms. Arch Biochem Biophys 2003;415:34-42.
30. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schächtele G: Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Gö6976. J Biol Chem 1993;268:9194-9197.
31. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
32. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Häussinger D: Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 2005;129:2009-2031.
33. Harris TE, Lawrence JC Jr: TOR signaling. Sci STKE 2003;212:re15.
34. Schliess F, vom Dahl S, Häussinger D: Insulin resistance by loop diuretics and hyperosmolarity in perfused rat liver. Biol Chem 2001;382:1063-1069.
35. Jones BA, Rao YP, Stravitz RT, Gores GJ: Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C. Am J Physiol 1997;272:G1109-G1115.
36. Beuers U, Probst I, Soroka C, Boyer JL, Kullak UG, Paumgartner G: Modulation of protein kinase C by taurolithocholic acid in isolated rat hepatocytes. Hepatology 1999;29:477-482.
37. Shah SA, Looby E, Volkov Y, Long A, Kelleher D: Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines. Eur J Cancer 2005;41:2160-2169.
38. Takayama S, White MF, Kahn CR: Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 1988;263:3440-3447.
39. Cortright RN, Azevedo JL, Jr., Zhou Q, Sinha M, Pories WJ, Itani SI, Dohm GL: Protein kinase C modulates insulin action in human skeletal muscle. Am J Physiol 2000;278:E553-E562.
40. Kimball SR, Siegfried BA, Jefferson LS: Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J Biol Chem 2004 24;279:54103-54109.
41. Mothe-Satney I, Gautier N, Hinault C, Lawrence J-CJ, Van Obberghen E: In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids. J Biol Chem 2004;279:42628-42637.
42. Korsheninnikova E, Van der Zon GC, Voshol PJ, Janssen GM, Havekes LM, Grefhorst A, Kuipers F, Reijngoud DJ, Romijn JA, Ouwens DM, Maassen JA: Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 2006;49:3049-3057.
43. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004;306:457-461.
44. Tsuchiya S, Tsuji M, Morio Y, Oguchi K: Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicol Lett 2006;166:14-149.
45. Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL: Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 2003;278:1810-17818.
46. + balance. Eur J Biochem 1991;199:467-474.
47. Häussinger D, Schliess F, Dombrowski F, vom Dahl S: Involvement of p38 MAPK in the regulation of proteolysis by liver cell hydration. Gastroenterology 1999;116:921-935.
48. Becker S, Reinehr R, Graf D, vom Dahl S, Häussinger D. Hydrophobic bile acids induce hepatocyte shrinkage via NADPH oxidase activation. Cell Physiol Biochem 2007;19:89-98.
49. Watkins JB, Sanders RA: Diabetes mellitus-induced alterations of hepatobiliary function. Pharmacol Rev 1995;47:1-23.